Search Results - Stephane Dalle
- Showing 1 - 20 results of 45
- Go to Next Page
-
1
Targeting Protein Kinases to Protect Beta-Cell Function and Survival in Diabetes by Stéphane Dalle
Published 2024-06-01
Article -
2
Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma by Valentin Benboubker, Félix Boivin, Stéphane Dalle, Stéphane Dalle, Julie Caramel
Published 2022-03-01
Article -
3
-
4
-
5
-
6
Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes by Stéphane Dalle, Amar Abderrahmani, Eric Renard, Eric Renard, Eric Renard
Published 2023-03-01
Article -
7
Bilateral uveitis and macular edema induced by Nivolumab: a case report by Claire Theillac, Morgane Straub, Anne-Laure Breton, Luc Thomas, Stéphane Dalle
Published 2017-12-01
Article -
8
-
9
-
10
-
11
-
12
-
13
-
14
Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanoma by Marie‐Alix Mangin, Amélie Boespflug, Delphine Maucort Boulch, Charles‐Hervé Vacheron, Isabelle Carpentier, Luc Thomas, Stéphane Dalle
Published 2021-05-01
Article -
15
Left ventricular ejection fraction decrease related to BRAF and/or MEK inhibitors in metastatic melanoma patients: A retrospective analysis by Mathilde Berger, Mona Amini‐Adlé, Delphine Maucort‐Boulch, Philip Robinson, Luc Thomas, Stéphane Dalle, Pierre‐Yves Courand
Published 2020-04-01
Article -
16
-
17
-
18
Diagnostic Concordance in Tertiary (Dermatologists-to-Experts) Teledermoscopy: A Final Diagnosis-Based Study on 290 Cases by Anne Marchetti, Stephane Dalle, Delphine Maucort Boulch, Mona Amini-Adl, Sébastien Debarbieux, Nicolas Poulalhon, Marie Perier-Muzet, Alice Phan, Luc Thomas
Published 2020-06-01
Article -
19
-
20
Evaluation of TTV replication as a biomarker of immune checkpoint inhibitors efficacy in melanoma patients. by Rémi Pescarmona, William Mouton, Thierry Walzer, Stéphane Dalle, Anaïs Eberhardt, Karen Brengel-Pesce, Marine Villard, Christine Lombard, Sophie Trouillet-Assant, Sébastien Viel
Published 2021-01-01
Article